EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Omicron BA.5 infection on maternal and neonatal outcomes

Lu Li, Ruitian Hou, Zan Mai, Li Liang, Zheng Li, Bin Long, Lin Chen, Ping Feng, Baojun Yang, Lijie Yang, Lianhua Tang, Peizhi Wang und 4 weitere

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1551602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Lu Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Physiological and immunological adaptations during pregnancy may elevate the risk of adverse perinatal and neonatal outcomes associated with SARS-CoV-2 infection. This retrospective study aimed to explore the clinical characteristics of pregnant women and the maternal and neonatal outcomes during pregnancy following Omicron BA.5 variant infection.

Methods

Clinical and laboratory data from 208 pregnant women with Omicron BA.5 infection were analyzed, including intrapartum and postpartum records of 24 infected parturients and their neonates, with comparisons made to uninfected controls. Multiple specimen types, including placental membranes and amniotic fluid, were collected for SARS-CoV-2 RNA detection.

Results

Among 208 infected pregnant women, 91.8% (191/208) had received at least one dose of inactivated SARS-CoV-2 vaccine. BA.5 infection in pregnant women exhibited viral load, clearance time and symptom profiles comparable to the general population, with no severe or critical illness being found. No significant differences were noted between pregnant women over and under 35 years. BA.5 infection reduced the white blood cell counts but did not aggravate the hypercoagulability compared to the uninfected controls. Neonates of infected mothers showed a higher rate of intrauterine hypoxia than those controls. However, no SARS-CoV-2 RNA was detectable in any of the neonatal oropharyngeal swabs as well as maternal specimens, including placental membranes, amniotic fluid, vaginal secretions, breast milk, venous blood and ascites.

Conclusion

This study demonstrates favorable maternal and neonatal outcomes in vaccinated pregnant women with BA.5 infection following timely medical intervention. Neonates born to infected mothers have an extremely low risk of vertical transmission. Nevertheless, enhanced prenatal care for pregnant women with COVID-19 remains essential to mitigate adverse neonatal outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Pregnancy Complications, InfectiousHumansFemalePregnancyInfant, NewbornAdultRetrospective StudiesPregnancy OutcomeViral LoadInfectious Disease Transmission, VerticalYoung AdultCOVID-19 VaccinesRNA, Viral

Stichwörter der Autor:innen

Omicron BA.5neonatepregnancyvaccinationvertical transmission

Substanzen

COVID-19 VaccinesRNA, Viral

Autor:innen und Institutionen

  • Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
  • Department of Pathogenic Biology and Immunology, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
  • Guangzhou National Laboratory, Guangzhou, China.
  • Department of Obstetrics and Gynecology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
  • Department of Stomatology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.

Zitieren

APA

Li, L., Hou, R., Mai, Z., Liang, L., Li, Z., Long, B., Chen, L., Feng, P., Yang, B., Yang, L., Tang, L., Wang, P., Zhong, F., Chu, M., Liang, H., & Tang, X. (2025). Impact of Omicron BA.5 infection on maternal and neonatal outcomes. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1551602

Vancouver

Li L, Hou R, Mai Z, Liang L, Li Z, Long B, et al. Impact of Omicron BA.5 infection on maternal and neonatal outcomes. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1551602

BibTeX
@article{Li2025,
  author = {Li, Lu and Hou, Ruitian and Mai, Zan and Liang, Li and Li, Zheng and Long, Bin and Chen, Lin and Feng, Ping and Yang, Baojun and Yang, Lijie and Tang, Lianhua and Wang, Peizhi and Zhong, Fan and Chu, Mei and Liang, Huichao and Tang, Xiaoping},
  title = {Impact of Omicron BA.5 infection on maternal and neonatal outcomes},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1551602}
}
Kostenlos starten →